Today: 14 May 2026
Browse Category

OTC:CRKN 30 September 2025

Crown Electrokinetics (CRWV/CRKN) Surges Amid Takeover Buzz – Key Facts & Analysis (Sept 30, 2025)

Crown Electrokinetics (CRWV/CRKN) Surges Amid Takeover Buzz – Key Facts & Analysis (Sept 30, 2025)

Crown agreed on June 9, 2025, to be acquired by Crown EK Acquisition LLC for $3.15 per share in cash; a special committee approved the deal as fair. The company’s board voted July 23 to voluntarily delist from Nasdaq after trading was suspended in March, and shares now trade OTC under CRKN. Q1 2025 revenue rose to $2.8 million, but net loss widened to $9.7 million. Board and auditor changes followed as Crown prepares to go private.

Stock Market Today

  • Top TSX Dividend Stocks To Watch In May 2026
    May 14, 2026, 9:12 AM EDT. Canadian investors eye top TSX dividend stocks in May 2026 amid geopolitical shifts and economic changes. Notable names include Great-West Lifeco (TSX:GWO) with a 3.5% yield, backed by stable earnings and a CA$68.28 billion market cap, and Lundin Gold (TSX:LUG) with a 5.6% yield, supported by strong revenue growth from its Ecuador mining operations. High dividend coverage and consistent payouts mark these stocks as potential buffers against market volatility. Other significant dividend payers are Rogers Sugar, Power Corporation, and Firm Capital Mortgage Investment, exhibiting yields from 3.09% to 8.61%. These selections reflect investor preference for income stability amid improving labor markets and heightened geopolitical caution.

Latest articles

Apple Backs Google in EU AI Fight as iPhone Rules Loom

Apple Backs Google in EU AI Fight as iPhone Rules Loom

14 May 2026
Apple warned the European Commission that proposed EU rules forcing Google’s Android to open core features to rival AI assistants could endanger privacy, security, and device performance. The Commission’s feedback period closed Wednesday, with a final decision expected by July 27. Apple argued the measures could set a precedent for its own platforms. Google also opposes the plan, calling it an “unwarranted intervention.”
Precigen Stock Jumps as Papzimeos Sales Change the Story for PGEN Investors

Precigen Stock Jumps as Papzimeos Sales Change the Story for PGEN Investors

14 May 2026
Precigen shares jumped 14.1% in early trading after first-quarter revenue reached $23.3 million, beating estimates, and net loss narrowed to $7.9 million from $54.2 million a year earlier. Papzimeos, its new RRP therapy, generated $21.6 million in net product revenue. The company ended March with $56.7 million in cash and expects current funds and Papzimeos sales to last through 2026.
POET Stock Jumps After $50 Million Lumilens AI Optics Order — The Bigger Test Comes Later

POET Stock Jumps After $50 Million Lumilens AI Optics Order — The Bigger Test Comes Later

14 May 2026
POET Technologies signed a supply and joint-development agreement with Lumilens, including a $50 million initial order for optical engines used in AI data-center networks. The companies said cumulative purchases could exceed $500 million over five years. POET shares rose 16% after the news. First engineering samples are expected in late 2026, with production targeted for 2027.
Go toTop